Monocytes from newly diagnosed treatment-naïve T2DM patients exhibited elevated expression of NLRP3 and ASC, as well as increased basal and DAMP-induced inflammasome activation. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.